{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:41:18Z","timestamp":1790710878313,"version":"4.1.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,19]],"date-time":"2018-11-19T00:00:00Z","timestamp":1542585600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,11,19]],"date-time":"2018-11-19T00:00:00Z","timestamp":1542585600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"crossref","award":["K08EY022737"],"award-info":[{"award-number":["K08EY022737"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"crossref","award":["P30 EY08098"],"award-info":[{"award-number":["P30 EY08098"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Wiegand Fellowship of the Eye and Ear Foundation"},{"name":"Initiative to Cure Glaucoma of the Eye and Ear Foundation of Pittsburgh"},{"name":"An unrestricted grant from Research to Prevent Blindness, New York, NY"},{"name":"An unrestricted grant from the Third Xiangya Hospital of Central South University for studying at the University of Pittsburgh"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1007\/s00417-018-4175-6","type":"journal-article","created":{"date-parts":[[2018,11,19]],"date-time":"2018-11-19T09:34:47Z","timestamp":1542620087000},"page":"101-109","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["RKI-1447, a Rho kinase inhibitor, causes ocular hypotension, actin stress fiber disruption, and increased phagocytosis"],"prefix":"10.1007","volume":"257","author":[{"given":"Yalong","family":"Dang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyal","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susannah","family":"Waxman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralitsa T.","family":"Loewen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7167-1213","authenticated-orcid":false,"given":"Nils A.","family":"Loewen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,19]]},"reference":[{"key":"4175_CR1","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.preteyeres.2013.09.001","volume":"37","author":"SF Janssen","year":"2013","unstructured":"Janssen SF, Gorgels TGMF, Ramdas WD et al (2013) The vast complexity of primary open angle glaucoma: disease genes, risks, molecular mechanisms and pathobiology. Prog Retin Eye Res 37:31\u201367","journal-title":"Prog Retin Eye Res"},{"key":"4175_CR2","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1001\/jama.2014.3192","volume":"311","author":"RN Weinreb","year":"2014","unstructured":"Weinreb RN, Aung T, Medeiros FA (2014) The pathophysiology and treatment of glaucoma: a review. JAMA 311:1901\u20131911","journal-title":"JAMA"},{"key":"4175_CR3","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1136\/bjophthalmol-2014-305908","volume":"99","author":"RN Weinreb","year":"2015","unstructured":"Weinreb RN, Ong T, Scassellati Sforzolini B et al (2015) A randomised, controlled comparison of latanoprostene bunod and latanoprost 0.005% in the treatment of ocular hypertension and open angle glaucoma: the VOYAGER study. Br J Ophthalmol 99:738\u2013745","journal-title":"Br J Ophthalmol"},{"issue":"12","key":"4175_CR4","doi-asserted-by":"publisher","first-page":"4886","DOI":"10.1167\/iovs.18-24943","volume":"1;59","author":"S Waxman","year":"2018","unstructured":"Waxman S, Wang C, Dang Y, Hong Y, Esfandiari H, Shah P, Lathrop KL, Loewen RT, Loewen NA (2018) Structure\u2013function changes of the porcine distal outflow tract in response to nitric oxide. Invest Ophthalmol Vis Sci 1;59(12):4886\u20134895","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4175_CR5","doi-asserted-by":"publisher","first-page":"C44","DOI":"10.1152\/ajpcell.00024.2018","volume":"315","author":"F McDonnell","year":"2018","unstructured":"McDonnell F, Dismuke WM, Overby DR, Stamer WD (2018) Pharmacological regulation of outflow resistance distal to Schlemm\u2019s canal. Am J Physiol Cell Physiol 315:C44\u2013C51","journal-title":"Am J Physiol Cell Physiol"},{"key":"4175_CR6","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1007\/s40265-014-0333-2","volume":"74","author":"KP Garnock-Jones","year":"2014","unstructured":"Garnock-Jones KP (2014) Ripasudil: first global approval. Drugs 74:2211\u20132215","journal-title":"Drugs"},{"key":"4175_CR7","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.1111\/aos.12829","volume":"94","author":"H Tanihara","year":"2016","unstructured":"Tanihara H, Inoue T, Yamamoto T et al (2016) One-year clinical evaluation of 0.4% ripasudil (K-115) in patients with open-angle glaucoma and ocular hypertension. Acta Ophthalmol 94:e26\u2013e34","journal-title":"Acta Ophthalmol"},{"key":"4175_CR8","doi-asserted-by":"publisher","first-page":"5025","DOI":"10.1158\/0008-5472.CAN-12-0954","volume":"72","author":"RA Patel","year":"2012","unstructured":"Patel RA, Forinash KD, Pireddu R et al (2012) RKI-1447 is a potent inhibitor of the Rho-associated ROCK kinases with anti-invasive and antitumor activities in breast cancer. Cancer Res 72:5025\u20135034","journal-title":"Cancer Res"},{"key":"4175_CR9","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nrm1128","volume":"4","author":"K Riento","year":"2003","unstructured":"Riento K, Ridley AJ (2003) Rocks: multifunctional kinases in cell behaviour. Nat Rev Mol Cell Biol 4:446\u2013456","journal-title":"Nat Rev Mol Cell Biol"},{"key":"4175_CR10","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1111\/j.1365-2443.2007.01073.x","volume":"12","author":"K Katoh","year":"2007","unstructured":"Katoh K, Kano Y, Ookawara S (2007) Rho-kinase dependent organization of stress fibers and focal adhesions in cultured fibroblasts. Genes Cells 12:623\u2013638","journal-title":"Genes Cells"},{"key":"4175_CR11","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.3892\/ijo.2013.2100","volume":"43","author":"J Wang","year":"2013","unstructured":"Wang J, Liu X, Zhong Y (2013) Rho\/Rho-associated kinase pathway in glaucoma (Review). Int J Oncol 43:1357\u20131367","journal-title":"Int J Oncol"},{"key":"4175_CR12","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1097\/IJG.0b013e318241b83c","volume":"21","author":"B Goldhagen","year":"2012","unstructured":"Goldhagen B, Proia AD, Epstein DL, Rao PV (2012) Elevated levels of RhoA in the optic nerve head of human eyes with glaucoma. J Glaucoma 21:530\u2013538","journal-title":"J Glaucoma"},{"key":"4175_CR13","unstructured":"National Library of Medicine (2014) Multiple dose-parallel-group study of AMA0076 in patients with primary open-angle glaucoma or ocular hypertension https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02136940 . Accessed 7 Sep 2017"},{"key":"4175_CR14","unstructured":"National Library of Medicine (2016) Double-masked study of PG324 ophthalmic solution in patients with open-angle glaucoma or ocular hypertension. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02674854 . Accessed 7 Sep 2017"},{"key":"4175_CR15","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.ophtha.2014.08.022","volume":"122","author":"J Bacharach","year":"2015","unstructured":"Bacharach J, Dubiner HB, Levy B et al (2015) Double-masked, randomized, dose-response study of AR-13324 versus latanoprost in patients with elevated intraocular pressure. Ophthalmology 122:302\u2013307","journal-title":"Ophthalmology"},{"key":"4175_CR16","first-page":"205","volume":"43","author":"M Choy","year":"2018","unstructured":"Choy M (2018) Pharmaceutical approval update. P T 43:205\u2013227","journal-title":"P T"},{"key":"4175_CR17","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1001\/jamaophthalmol.2015.0525","volume":"133","author":"H Tanihara","year":"2015","unstructured":"Tanihara H, Inoue T, Yamamoto T et al (2015) Additive intraocular pressure-lowering effects of the Rho kinase inhibitor ripasudil (K-115) combined with timolol or latanoprost: a report of 2 randomized clinical trials. JAMA Ophthalmol 133:755\u2013761","journal-title":"JAMA Ophthalmol"},{"key":"4175_CR18","first-page":"883","volume":"8","author":"SK Wang","year":"2014","unstructured":"Wang SK, Chang RT (2014) An emerging treatment option for glaucoma: Rho kinase inhibitors. Clin Ophthalmol 8:883\u2013890","journal-title":"Clin Ophthalmol"},{"key":"4175_CR19","doi-asserted-by":"publisher","unstructured":"Martin MP, Zhu J-Y, Schonbrunn E (2012) Rho-associated protein kinase 1 (ROCK 1) IN COMPLEX WITH RKI1447. https:\/\/doi.org\/10.2210\/pdb3TWJ\/pdb","DOI":"10.2210\/pdb3TWJ\/pdb"},{"key":"4175_CR20","doi-asserted-by":"publisher","first-page":"5468","DOI":"10.1038\/s41598-018-23861-x","volume":"8","author":"Y Dang","year":"2018","unstructured":"Dang Y, Waxman S, Wang C et al (2018) A porcine ex vivo model of pigmentary glaucoma. Sci Rep 8:5468","journal-title":"Sci Rep"},{"key":"4175_CR21","first-page":"65","volume":"178","author":"PG McMenamin","year":"1991","unstructured":"McMenamin PG, Steptoe RJ (1991) Normal anatomy of the aqueous humour outflow system in the domestic pig eye. J Anat 178:65\u201377","journal-title":"J Anat"},{"key":"4175_CR22","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.exer.2005.03.014","volume":"81","author":"J Ruiz-Ederra","year":"2005","unstructured":"Ruiz-Ederra J, Garc\u00eda M, Hern\u00e1ndez M et al (2005) The pig eye as a novel model of glaucoma. Exp Eye Res 81:561\u2013569","journal-title":"Exp Eye Res"},{"key":"4175_CR23","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1167\/iovs.15-18125","volume":"57","author":"RT Loewen","year":"2016","unstructured":"Loewen RT, Roy P, Park DB et al (2016) A porcine anterior segment perfusion and transduction model with direct visualization of the trabecular meshwork. Invest Ophthalmol Vis Sci 57:1338\u20131344","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4175_CR24","doi-asserted-by":"publisher","first-page":"e3629","DOI":"10.7717\/peerj.3629","volume":"5","author":"Y Dang","year":"2017","unstructured":"Dang Y, Waxman S, Wang C et al (2017) Freeze-thaw decellularization of the trabecular meshwork in an ex vivo eye perfusion model. PeerJ 5:e3629","journal-title":"PeerJ"},{"key":"4175_CR25","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1016\/j.exer.2006.08.008","volume":"83","author":"B Tian","year":"2006","unstructured":"Tian B, Hu Y, Gabelt BT, Kaufman PL (2006) Factors affecting outflow facility calculations. Exp Eye Res 83:1515\u20131520","journal-title":"Exp Eye Res"},{"key":"4175_CR26","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1111\/ceo.12796","volume":"44","author":"Y Dang","year":"2016","unstructured":"Dang Y, Kaplowitz K, Parikh HA et al (2016) Steroid-induced glaucoma treated with trabecular ablation in a matched comparison with primary open-angle glaucoma. Clin Exp Ophthalmol 44:783\u2013788","journal-title":"Clin Exp Ophthalmol"},{"key":"4175_CR27","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3109\/02713683.2016.1156133","volume":"42","author":"G-Q Wang","year":"2017","unstructured":"Wang G-Q, Dang Y-L, Huang Q et al (2017) In vitro evaluation of the effects of intraocular lens material on lens epithelial cell proliferation, migration, and transformation. Curr Eye Res 42:72\u201378","journal-title":"Curr Eye Res"},{"key":"4175_CR28","doi-asserted-by":"publisher","first-page":"6059","DOI":"10.1167\/iovs.10-7108","volume":"52","author":"Q Fan","year":"2011","unstructured":"Fan Q, Teo Y-Y, Saw S-M (2011) Application of advanced statistics in ophthalmology. Invest Ophthalmol Vis Sci 52:6059\u20136065","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4175_CR29","unstructured":"R Development Core Team (2015) R: a language and environment for statistical computing. https:\/\/www.gbif.org\/tool\/81287\/r-a-language-and-environment-for-statistical-computing . Accessed 7 Sep 2018"},{"key":"4175_CR30","first-page":"1091","volume":"41","author":"P Hogg","year":"2000","unstructured":"Hogg P, Calthorpe M, Batterbury M, Grierson I (2000) Aqueous humor stimulates the migration of human trabecular meshwork cells in vitro. Invest Ophthalmol Vis Sci 41:1091\u20131098","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4175_CR31","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/S0002-9394(02)02289-4","volume":"135","author":"Y Siddiqui","year":"2003","unstructured":"Siddiqui Y, Ten Hulzen RD, Cameron JD et al (2003) What is the risk of developing pigmentary glaucoma from pigment dispersion syndrome? Am J Ophthalmol 135:794\u2013799","journal-title":"Am J Ophthalmol"},{"key":"4175_CR32","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/S0002-9394(14)73635-9","volume":"115","author":"R Ritch","year":"1993","unstructured":"Ritch R, Steinberger D, Liebmann JM (1993) Prevalence of pigment dispersion syndrome in a population undergoing glaucoma screening. Am J Ophthalmol 115:707\u2013710","journal-title":"Am J Ophthalmol"},{"key":"4175_CR33","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1038\/eye.2008.328","volume":"23","author":"G Qing","year":"2009","unstructured":"Qing G, Wang N, Tang X et al (2009) Clinical characteristics of pigment dispersion syndrome in Chinese patients. Eye 23:1641\u20131646","journal-title":"Eye"},{"key":"4175_CR34","first-page":"205","volume":"18","author":"A Llobet","year":"2003","unstructured":"Llobet A, Gasull X, Gual A (2003) Understanding trabecular meshwork physiology: a key to the control of intraocular pressure? News Physiol Sci 18:205\u2013209","journal-title":"News Physiol Sci"},{"key":"4175_CR35","unstructured":"Abu-Hassan DW, Acott TS, Kelley MJ (2014) The trabecular meshwork: a basic review of form and function. J Ocul Biol Dis Infor 2:1\u201322"},{"key":"4175_CR36","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1002\/jps.20285","volume":"94","author":"E Nakajima","year":"2005","unstructured":"Nakajima E, Nakajima T, Minagawa Y et al (2005) Contribution of ROCK in contraction of trabecular meshwork: proposed mechanism for regulating aqueous outflow in monkey and human eyes. J Pharm Sci 94:701\u2013708","journal-title":"J Pharm Sci"},{"key":"4175_CR37","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S0014-4827(03)00114-9","volume":"287","author":"B Doornaert","year":"2003","unstructured":"Doornaert B, Leblond V, Planus E et al (2003) Time course of actin cytoskeleton stiffness and matrix adhesion molecules in human bronchial epithelial cell cultures. Exp Cell Res 287:199\u2013208","journal-title":"Exp Cell Res"},{"key":"4175_CR38","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.exer.2016.07.011","volume":"158","author":"K Wang","year":"2017","unstructured":"Wang K, Read AT, Sulchek T, Ethier CR (2017) Trabecular meshwork stiffness in glaucoma. Exp Eye Res 158:3\u201312","journal-title":"Exp Eye Res"},{"key":"4175_CR39","doi-asserted-by":"publisher","first-page":"3365","DOI":"10.1021\/acsnano.5b07162","volume":"10","author":"A Calzado-Mart\u00edn","year":"2016","unstructured":"Calzado-Mart\u00edn A, Encinar M, Tamayo J et al (2016) Effect of actin organization on the stiffness of living breast cancer cells revealed by peak-force modulation atomic force microscopy. ACS Nano 10:3365\u20133374","journal-title":"ACS Nano"},{"key":"4175_CR40","doi-asserted-by":"publisher","first-page":"4447","DOI":"10.1167\/iovs.15-16739","volume":"56","author":"VK Raghunathan","year":"2015","unstructured":"Raghunathan VK, Morgan JT, Park SA et al (2015) Dexamethasone stiffens trabecular meshwork, trabecular meshwork cells, and matrix. Invest Ophthalmol Vis Sci 56:4447\u20134459","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4175_CR41","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s10237-015-0706-9","volume":"15","author":"N Gavara","year":"2016","unstructured":"Gavara N, Chadwick RS (2016) Relationship between cell stiffness and stress fiber amount, assessed by simultaneous atomic force microscopy and live-cell fluorescence imaging. Biomech Model Mechanobiol 15:511\u2013523","journal-title":"Biomech Model Mechanobiol"},{"key":"4175_CR42","doi-asserted-by":"publisher","first-page":"15362","DOI":"10.18632\/oncotarget.3798","volume":"6","author":"JT Morgan","year":"2015","unstructured":"Morgan JT, Raghunathan VK, Chang Y-R et al (2015) The intrinsic stiffness of human trabecular meshwork cells increases with senescence. Oncotarget 6:15362\u201315374","journal-title":"Oncotarget"},{"key":"4175_CR43","first-page":"1376","volume":"9","author":"J Peng","year":"2016","unstructured":"Peng J, Feng X-Y, Ye Z-M et al (2016) Effects of dexamethasone and HA1077 on actin cytoskeleton and \u03b2-catenin in cultured human trabecular meshwork cells. Int J Ophthalmol 9:1376\u20131380","journal-title":"Int J Ophthalmol"},{"key":"4175_CR44","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1002\/cm.20049","volume":"60","author":"AF Clark","year":"2005","unstructured":"Clark AF, Brotchie D, Read AT et al (2005) Dexamethasone alters F-actin architecture and promotes cross-linked actin network formation in human trabecular meshwork tissue. Cell Motil Cytoskeleton 60:83\u201395","journal-title":"Cell Motil Cytoskeleton"},{"key":"4175_CR45","first-page":"1029","volume":"42","author":"PV Rao","year":"2001","unstructured":"Rao PV, Deng PF, Kumar J, Epstein DL (2001) Modulation of aqueous humor outflow facility by the Rho kinase-specific inhibitor Y-27632. Invest Ophthalmol Vis Sci 42:1029\u20131037","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4175_CR46","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.exer.2004.08.029","volume":"80","author":"PV Rao","year":"2005","unstructured":"Rao PV, Deng P, Sasaki Y, Epstein DL (2005) Regulation of myosin light chain phosphorylation in the trabecular meshwork: role in aqueous humour outflow facility. Exp Eye Res 80:197\u2013206","journal-title":"Exp Eye Res"},{"key":"4175_CR47","doi-asserted-by":"publisher","first-page":"4130","DOI":"10.1167\/iovs.05-0164","volume":"46","author":"M Zhang","year":"2005","unstructured":"Zhang M, Rao PV (2005) Blebbistatin, a novel inhibitor of myosin II ATPase activity, increases aqueous humor outflow facility in perfused enucleated porcine eyes. Invest Ophthalmol Vis Sci 46:4130\u20134138","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4175_CR48","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1006\/exer.2002.2009","volume":"75","author":"M Honjo","year":"2002","unstructured":"Honjo M, Inatani M, Kido N et al (2002) A myosin light chain kinase inhibitor, ML-9, lowers the intraocular pressure in rabbit eyes. Exp Eye Res 75:135\u2013142","journal-title":"Exp Eye Res"},{"key":"4175_CR49","first-page":"137","volume":"42","author":"M Honjo","year":"2001","unstructured":"Honjo M, Tanihara H, Inatani M et al (2001) Effects of rho-associated protein kinase inhibitor Y-27632 on intraocular pressure and outflow facility. Invest Ophthalmol Vis Sci 42:137\u2013144","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4175_CR50","first-page":"288","volume":"11","author":"PV Rao","year":"2005","unstructured":"Rao PV, Deng P, Maddala R et al (2005) Expression of dominant negative Rho-binding domain of Rho-kinase in organ cultured human eye anterior segments increases aqueous humor outflow. Mol Vis 11:288\u2013297","journal-title":"Mol Vis"},{"key":"4175_CR51","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1242\/jcs.114.6.1061","volume":"114","author":"RC May","year":"2001","unstructured":"May RC, Machesky LM (2001) Phagocytosis and the actin cytoskeleton. J Cell Sci 114:1061\u20131077","journal-title":"J Cell Sci"},{"key":"4175_CR52","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-50047-8","volume-title":"The actin cytoskeleton and bacterial infection","author":"HG Mannherz","year":"2017","unstructured":"Mannherz HG (2017) The actin cytoskeleton and bacterial infection. Springer, New York City"},{"key":"4175_CR53","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/BF02385060","volume":"175","author":"JW Rohen","year":"1968","unstructured":"Rohen JW, van der Zypen E (1968) The phagocytic activity of the trabecular meshwork endothelium. Graefes Arch Clin Exp Ophthalmol 175:143\u2013160","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"4175_CR54","first-page":"1902","volume":"38","author":"Y Matsumoto","year":"1997","unstructured":"Matsumoto Y, Johnson DH (1997) Dexamethasone decreases phagocytosis by human trabecular meshwork cells in situ. Invest Ophthalmol Vis Sci 38:1902\u20131907","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4175_CR55","doi-asserted-by":"publisher","first-page":"5603","DOI":"10.1093\/emboj\/20.20.5603","volume":"20","author":"F Castellano","year":"2001","unstructured":"Castellano F, Le Clainche C, Patin D et al (2001) A WASp\u2013VASP complex regulates actin polymerization at the plasma membrane. EMBO J 20:5603\u20135614","journal-title":"EMBO J"},{"key":"4175_CR56","doi-asserted-by":"publisher","first-page":"5242","DOI":"10.1167\/iovs.12-9825","volume":"53","author":"LJ Camras","year":"2012","unstructured":"Camras LJ, Stamer WD, Epstein D et al (2012) Differential effects of trabecular meshwork stiffness on outflow facility in normal human and porcine eyes. Invest Ophthalmol Vis Sci 53:5242\u20135250","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4175_CR57","doi-asserted-by":"publisher","first-page":"2831","DOI":"10.1167\/iovs.16-19541","volume":"57","author":"RT Loewen","year":"2016","unstructured":"Loewen RT, Brown EN, Scott G et al (2016) Quantification of focal outflow enhancement using differential canalograms. Invest Ophthalmol Vis Sci 57:2831\u20132838","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4175_CR58","doi-asserted-by":"publisher","first-page":"e0151754","DOI":"10.1371\/journal.pone.0151754","volume":"11","author":"RT Loewen","year":"2016","unstructured":"Loewen RT, Brown EN, Roy P et al (2016) Regionally discrete aqueous humor outflow quantification using fluorescein canalograms. PLoS One 11:e0151754","journal-title":"PLoS One"},{"key":"4175_CR59","doi-asserted-by":"publisher","first-page":"34705","DOI":"10.1038\/srep34705","volume":"6","author":"HA Parikh","year":"2016","unstructured":"Parikh HA, Loewen RT, Roy P et al (2016) Differential canalograms detect outflow changes from trabecular micro-bypass stents and ab interno trabeculectomy. Sci Rep 6:34705","journal-title":"Sci Rep"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-018-4175-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-018-4175-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-018-4175-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T07:45:24Z","timestamp":1662450324000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-018-4175-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,19]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["4175"],"URL":"https:\/\/doi.org\/10.1007\/s00417-018-4175-6","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,19]]},"assertion":[{"value":"5 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors. No animals were sacrificed for the purpose of doing research. An approval by an ethics committee or Institutional Animal Care and Use Committee was not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}